tiprankstipranks
Trending News
More News >
JBT Marel (JBTM)
NYSE:JBTM
Advertisement

JBT Marel (JBTM) AI Stock Analysis

Compare
246 Followers

Top Page

JBTM

JBT Marel

(NYSE:JBTM)

Rating:62Neutral
Price Target:
$144.00
▲(6.09% Upside)
JBT Marel's overall stock score is primarily driven by its stable financial foundation and positive earnings call sentiment, which highlight strong performance and synergy progress. However, the lack of technical analysis data and negative valuation metrics due to a net loss weigh down the score. Addressing profitability and operational efficiency will be crucial for future improvement.
Positive Factors
Earnings
Upgrading JBT Marel to Outperform, from Market Perform, following the company’s strong second-quarter results.
Financial Performance
Shares of JBT Marel were up 3% in after-hours trading after the company reported better-than-expected second-quarter results.
Order Momentum
Order momentum continued in first quarter 2025 (+12% year-over-year), with record bookings at Marel led by poultry, implying year-over-year growth starting at 19% to roughly $510 million.
Negative Factors
Guidance Suspension
The decision to suspend full year 2025 guidance appears to stem from an abundance of caution, with JBT Marel calling out prolonged periods of macro uncertainty as historically poor for the more cyclical equipment piece of the business.
Managerial Challenges
The largest issue is managerial bandwidth against a backdrop of decision paralysis due to ongoing tariff uncertainty.
Tariff Uncertainty
The looming potential of 50% EU tariffs adds another layer of complexity during an already complex integration process.

JBT Marel (JBTM) vs. SPDR S&P 500 ETF (SPY)

JBT Marel Business Overview & Revenue Model

Company DescriptionJBT Marel Corporation provides technology solutions to food and beverage industry in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers value-added processing that includes chilling, mixing/grinding, injecting, blending, marinating, tumbling, flattening, forming, portioning, coating, cooking, frying, freezing, extracting, pasteurizing, sterilizing, concentrating, high pressure processing, weighing, inspecting, filling, closing, sealing, end of line material handling, and packaging solutions to the food, beverage, and health market. In addition, it offers automated guided vehicle systems for material movement in the manufacturing, warehouse, and medical facilities. It serves baby food, bakery and confectionery, citrus processing, fruits and nuts, juices, non-food, pet food, pharmaceutical, plant- based beverages and protein, poultry, meat, and seafood, ready meals, oils, soups, sauces, seasoning and dressings, automotive, building material, tissue, paper, and packaging, hospitals, pharma and life sciences, fast moving consumer goods, manufacturing, warehousing, and other industries. The company markets and sells its products and solutions through direct sales force, independent distributors, sales representatives, and technical service teams. The company was formerly known as John Bean Technologies Corporation and changed its name to JBT Marel Corporation in January 2025. JBT Marel Corporation was incorporated in 1994 and is headquartered in Chicago, Illinois.
How the Company Makes MoneyJBT Marel generates revenue through multiple streams, including the sale of processing equipment, systems, and automation solutions to food manufacturers. The company also earns income from service contracts, maintenance, and spare parts, which provide ongoing support to its clients after the initial equipment purchase. Additionally, JBTM forms strategic partnerships with industry leaders and leverages its technological expertise to develop tailored solutions, thereby enhancing its market presence and driving sales. The recurring nature of its service agreements contributes to a stable revenue base, while new product innovations and expansions into emerging markets further bolster its earnings potential.

JBT Marel Earnings Call Summary

Earnings Call Date:Aug 04, 2025
(Q2-2025)
|
% Change Since: 1.59%|
Next Earnings Date:Nov 06, 2025
Earnings Call Sentiment Positive
The earnings call reflected a positive sentiment overall, with strong performance in Q2, significant progress in synergies, and improved cash flow and leverage. However, challenges such as tariff costs, variability in geographic performance, and softness in certain segments were noted.
Q2-2025 Updates
Positive Updates
Strong Q2 Performance
JBT posted a strong performance in the second quarter, with adjusted EBITDA margins and adjusted EPS exceeding expectations. Total revenue was $935 million, with a year-over-year growth of 13% in the JBT segment and Marel segment achieving a revenue of $480 million.
Significant Progress in Synergies and Cash Flow
The company realized year-over-year synergy savings of $5 million in operating expense and $3 million in supply chain. Free cash flow for the first half of 2025 was $106 million, including $88 million in the second quarter, supported by working capital management and customer deposits.
Improvement in Leverage
Leverage decreased to below 3.4x at the end of the second quarter, compared to 3.8x in the first quarter and 4x at the close of the transaction. The bank leverage ratio was 2.8x as of June 30.
Poultry Industry Demand
Continued equipment investment from the poultry industry, the largest end market, with a pipeline expected to provide support into next year. The combined pipeline of opportunities in North America grew by approximately 15% in the last 6 months.
Integration and Cross-Selling Benefits
Successful integration of JBT and Marel portfolios, capturing benefits from cross-selling, with a combined pipeline of opportunities in North America increasing by 15% over the last 6 months.
Negative Updates
Tariff Costs
Incurred approximately $9 million in gross tariff costs in Q2, with a continued impact expected in Q3 and Q4. The company is working on mitigating actions, including supply chain adjustments and pricing actions.
Pharma and Pet Food Demand Softness
Quarterly demand for pharma and pet food was softer, indicating challenges in these market segments.
Geographic Performance Variability
North America was relatively soft, while Asia Pacific continued to be choppy. This highlights regional challenges in demand.
Impairment Charge
An $11 million impairment charge on a joint venture investment was incurred as a result of the JBT combination with Marel.
Company Guidance
During JBT Marel's earnings call for the second quarter of 2025, the company offered robust guidance reflecting a strong performance. Total revenue for the quarter was $935 million, surpassing the midpoint of guidance by $35 million, with $21 million attributed to favorable foreign exchange impacts. JBT Marel reported adjusted EBITDA margins of 16.7%, outperforming guidance by 180 basis points, driven by a favorable mix of recurring revenue and higher-margin equipment. The company's backlog stood at $1.4 billion, providing solid support for future revenue. The poultry sector, JBT Marel's largest end market, showed continued equipment investment, contributing to a combined order total of $938 million, including a $22 million favorable year-over-year foreign exchange translation. For the full year 2025, JBT Marel expects revenue of $3.7 billion at the midpoint, with adjusted EBITDA margins ranging from 15.25% to 16% and adjusted EPS between $5.45 and $6.15. The company anticipates achieving $35 million to $40 million in expected in-year synergy savings and an annualized run rate of $80 million to $90 million in savings by the end of 2025.

JBT Marel Financial Statement Overview

Summary
JBT Marel exhibits a stable financial foundation with strong cash generation capabilities and improved balance sheet strength. However, the recent net loss and declining profit margins highlight the need for operational efficiencies and cost control. The company should focus on reversing the net income trend to sustain long-term growth.
Income Statement
65
Positive
The income statement shows a mixed performance. The revenue growth rate for TTM is strong compared to the previous annual period, but the company posted a negative net income. Gross profit margin remains healthy, yet the net profit margin is concerning due to the significant net loss in the TTM. EBIT and EBITDA margins have decreased, reflecting challenges in maintaining operational efficiency.
Balance Sheet
72
Positive
The balance sheet is relatively robust with a high equity ratio, indicating strong capitalization. Debt levels have been reduced significantly, improving the debt-to-equity ratio favorably. However, the return on equity has been negatively impacted by the net loss, which may be a potential risk if profitability issues persist.
Cash Flow
78
Positive
Cash flow metrics are solid, with a strong operating cash flow to net income ratio indicating effective cash generation from operations. Free cash flow has grown, showing good liquidity management. However, the substantial increase in financing cash flow suggests reliance on external funding, which could indicate potential liquidity concerns in the future if not managed well.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.71B1.72B1.66B1.59B1.40B1.73B
Gross Profit969.70M626.50M585.70M529.40M482.10M533.70M
EBITDA109.60M204.20M268.70M212.50M202.80M231.20M
Net Income-137.70M85.40M582.60M137.40M119.10M108.80M
Balance Sheet
Total Assets8.25B3.41B2.71B2.64B2.14B1.81B
Cash, Cash Equivalents and Short-Term Investments111.80M1.23B483.30M71.70M78.80M47.50M
Total Debt410.20M1.25B646.40M977.90M674.40M524.90M
Total Liabilities3.88B1.87B1.22B1.74B1.39B1.17B
Stockholders Equity4.37B1.54B1.49B905.40M750.20M637.10M
Cash Flow
Free Cash Flow198.10M194.70M19.10M50.60M123.20M217.70M
Operating Cash Flow235.00M232.60M74.20M135.20M174.90M252.00M
Investing Cash Flow-1.78B-41.30M729.30M-413.20M-270.50M-37.30M
Financing Cash Flow1.20B561.80M-354.10M270.60M80.80M-207.40M

JBT Marel Technical Analysis

Technical Analysis Sentiment
Positive
Last Price135.74
Price Trends
50DMA
126.76
Positive
100DMA
118.88
Positive
200DMA
121.07
Positive
Market Momentum
MACD
2.79
Positive
RSI
55.73
Neutral
STOCH
31.20
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JBTM, the sentiment is Positive. The current price of 135.74 is above the 20-day moving average (MA) of 134.35, above the 50-day MA of 126.76, and above the 200-day MA of 121.07, indicating a bullish trend. The MACD of 2.79 indicates Positive momentum. The RSI at 55.73 is Neutral, neither overbought nor oversold. The STOCH value of 31.20 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JBTM.

JBT Marel Risk Analysis

JBT Marel disclosed 58 risk factors in its most recent earnings report. JBT Marel reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

JBT Marel Peers Comparison

Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$8.75B28.2017.75%0.69%2.96%12.62%
76
Outperform
$6.82B23.6413.91%1.61%3.15%14.18%
75
Outperform
$4.00B27.0517.33%1.03%10.19%20.71%
74
Outperform
$9.43B45.0515.02%8.90%29.18%
66
Neutral
$2.26B40.448.37%0.66%9.64%-24.68%
64
Neutral
$11.07B17.166.44%2.05%2.75%-15.88%
62
Neutral
$7.05B40.40-4.70%0.22%64.69%-112.14%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JBTM
JBT Marel
135.74
47.61
54.02%
FLS
Flowserve
52.14
7.60
17.06%
MWA
Mueller Water Products
25.61
6.26
32.35%
SPXC
SPX
201.57
53.87
36.47%
SXI
Standex International
187.67
22.83
13.85%
WTS
Watts Water Technologies
262.24
85.46
48.34%

JBT Marel Corporate Events

Executive/Board ChangesShareholder Meetings
JBT Marel Stockholders Approve Key Proposals at Annual Meeting
Neutral
May 20, 2025

On May 15, 2025, JBT Marel Corporation held its Annual Meeting of Stockholders where three key proposals were voted on. The stockholders re-elected three directors, approved executive compensation on an advisory basis, and ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the 2025 fiscal year.

The most recent analyst rating on (JBTM) stock is a Sell with a $85.00 price target. To see the full list of analyst forecasts on JBT Marel stock, see the JBTM Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 07, 2025